keynote001
This is an old revision of the document!
The 2015 KEYNOTE-001 clinical trial for the Treatment of NSCLC using Pembrolizumab
The 2015 KEYNOTE-001 Adverse Effects
keynote001.1675896676.txt.gz · Last modified: 2025/02/01 17:00 (external edit)